BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 9, 2016
View Archived Issues
Acceleron initiates phase II study of ACE-083 in facioscapulohumeral muscular dystrophy
Read More
Novel drug targets described at the ACR/ARHP annual meeting
Read More
Regulus unveils new drug development candidates
Read More
FDA grants orphan drug designation to VK-0214 for X-linked adrenoleukodystrophy
Read More
Cristal Therapeutics, iTeos Therapeutics to develop immuno-oncology products
Read More
Dosing begins in phase III program of ReVance Therapeutics' daxibotulinumtoxinA
Read More
Aclaris Therapeutics clear to begin phase I testing of ATI-50001
Read More
Abivax provides update on clinical development program for ABX-464
Read More
Blisibimod BRIGHT-SC study demonstrates positive trends in the week 48 analysis
Read More
Arcturus Therapeutics announces collaboration with Takeda Pharmaceutical
Read More
First patient dosed in phase II/III trial of 18F-DCFPyL imaging agent
Read More
First-in-human data reported for Merck KGaA's bifunctional immunotherapy antibody
Read More
Cabozantinib meets endpoints in phase II lung cancer study
Read More
FDA and European approvals granted to begin clinical testing of Lyme disease vaccine candidate
Read More
Phase III STEADFAST study of Actimmune does not meet primary endpoint
Read More
Novel bispecific antibody NI-1701 active in B-cell cancer models
Read More
AL-S Pharma created to develop innovative therapy for patients with ALS
Read More
AstraZeneca and Lilly enter agreement for second drug for Alzheimer's
Read More
Gilead Sciences submits NDA for sofosbuvir/voxilaprevir/velpatasvir
Read More
MicroRNA identified as diagnostic, prognostic biomarker in acute myocardial infarction
Read More
EMA accepts for review MAA for dupilumab in atopic dermatitis
Read More
Cadila Healthcare discloses new kappa-opioid receptor agonists
Read More
BioHaven Pharmaceutical's BHV-0223 granted orphan drug status in U.S. for ALS
Read More
Universite de Geneve patents 5-aminolevulinic acid derivatives
Read More
ChemoCentryx describes novel C-C chemokine receptor type 2 ligands
Read More
Forge Therapeutics and Evotec enter strategic alliance to develop novel LpxC inhibitors
Read More
Voyager presents positive interim results from phase Ib trial of VY-AADC01
Read More
Amicus Therapeutics reports data from phase I/II study of ATB-200/AT-2221
Read More
European Commission grants conditional marketing authorization for Venclyxto
Read More
FDA grants orphan status to RPGR gene therapy for retinitis pigmentosa
Read More